Gilead: STAT+: Gilead is urged to rework licensing deals for groundbreaking HIV prevention drug
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences may need to issue compulsory licenses.
Read full article »
Gilead is a California-based biopharmaceutical company that develops and commercializes antiviral drugs for a wide range of diseases.
Read more